Takeda’s Half-Year Sales Slip on LLP Transfer, but Profits Zoom

Takeda President and CEO Christophe Weber Takeda Pharmaceutical saw its half-year revenue dip due to the stronger yen and divestitures including the transfer of long-listed products (LLPs) to a joint venture with Teva, but its profit grew strongly on the...read more